Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,602.81
(
0.31%
)
US TECH 100
23,510.40
(
0.48%
)
Dow Jones
46,604.46
(
0.21%
)
Brent Oil
107.24
(
-1.77%
)
Bitcoin
69,834.39
(
1.20%
)
News Focus
News Focus
Post# of 257363
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

vinmantoo

Send PM Follow Ignore
Followers 28
Posts 4692
Boards Moderated 0
Alias Born 07/25/2007

vinmantoo

Re: None

Tuesday, 05/03/2016 1:32:08 AM

Tuesday, May 03, 2016 1:32:08 AM

Post# of 257363
Bayer licenses PGNX's anti-PMSA antibody technology for use in radiolabeled therapeutic antibodies in prostate cancer. No terms were announced so it is hard to know how much this means for PGNX.

http://finance.yahoo.com/news/progenics-licenses-psma-antibody-technology-123000000.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today